Search Results 61-70 of 17719 for ulcerative colitis

  1. Surgery remains an important treatment option for pediatric inflammatory bowel disease (IBD) - Mayo Clinic

    New medications have improved pediatric IBD care, but surgery is still an important option to cure ulcerative colitis and reduce Crohn's disease symptoms.

  2. Mesalamine dose may lower marker of bowel inflammation Videos - Mayo Clinic

    A lower level of calprotectin is associated with a lower risk of having an ulcerative colitis flare. In inflammatory bowel disease (IBD), there can be a ...

  3. Clinical Trials - TD-1473 for Active Ulcerative Colitis (UC)

    This exploratory study will also serve as a signal seeking endeavor to demonstrate biologic effect associated with TD-1473 through biomarker analysis and ...

  4. Long-Term Study Of CP-690,550 in Subjects with Ulcerative Colitis - Mayo Clinic

    This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP- ...

  5. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  6. Inflammatory Bowel Disease Diagnoses Rising - Mayo Clinic News Network

    ... ulcerative colitis – the main conditions that comprise inflammatory bowel disease (IBD) – are on the rise. “More people are being diagnosed with IBD than 15 ...

  7. Microscopic colitis - Diagnosis and treatment - Mayo Clinic

    Related. Products & Services. A Book: Mayo Clinic on Crohn's Disease and Ulcerative Colitis ...

  8. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview ... ulcerative colitis (UC). Participation eligibility. Participant eligibility ...

  9. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

  10. Mayo Clinic Q and A: Treating inflammatory bowel disease

    It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...